Source:http://linkedlifedata.com/resource/pubmed/id/21300047
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8-9
|
pubmed:dateCreated |
2011-5-16
|
pubmed:abstractText |
Multiple myeloma (MM) was the first hematological malignancy in which a prognostic relevance of bone marrow (BM) angiogenesis was reported. Microenvironment formed by reactive oxygen species, growth factors and chemokines initiates the process of BM angiogenesis. Among the angiopoietins, angiopoietin-1 is involved in vessel stability, whereas angiopoietin-2 is involved in vessel sprouting.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1873-2933
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
590-5
|
pubmed:meshHeading |
pubmed-meshheading:21300047-Adult,
pubmed-meshheading:21300047-Aged,
pubmed-meshheading:21300047-Angiopoietin-1,
pubmed-meshheading:21300047-Angiopoietin-2,
pubmed-meshheading:21300047-Case-Control Studies,
pubmed-meshheading:21300047-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21300047-Female,
pubmed-meshheading:21300047-Humans,
pubmed-meshheading:21300047-Male,
pubmed-meshheading:21300047-Middle Aged,
pubmed-meshheading:21300047-Multiple Myeloma,
pubmed-meshheading:21300047-Vascular Endothelial Growth Factors
|
pubmed:year |
2011
|
pubmed:articleTitle |
Angiopoietin-2: a potential novel diagnostic marker in multiple myeloma.
|
pubmed:affiliation |
Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
|
pubmed:publicationType |
Journal Article
|